Bevenopran
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
5-[2-Methoxy-4-[[2-(oxan-4-yl)ethylamino]methyl]phenoxy]pyrazine-2-carboxamide
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 676500-67-7 |
PubChem | CID: 10452732 |
ChemSpider | 8628148 |
Chemical data | |
Formula | C20H26N4O4 |
Molecular mass | 386.44484 g/mol |
|
|
|
Bevenopran (INN, USAN) (former developmental code names CB-5945, ADL-5945, MK-2402, OpRA III) is a peripherally selective μ- and δ-opioid receptor antagonist that was under development by Cubist Pharmaceuticals for the treatment of chronic opioid-induced constipation.[1][2][3] It reached phase III clinical trials for this indication before being discontinued.[4][5]
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Combating Opioid-Induced Constipation: New and Emerging Therapies
- ↑ Bevenopran
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Amines
- Carboxamides
- Drugs acting on the gastrointestinal system and metabolism
- Laxatives
- Opioid antagonists
- Peripherally selective drugs
- Pyrazines
- Gastrointestinal system drug stubs